Personal information

Emails & domains

Verified email addresses

Keywords

Financial toxicity, Quality of Life, Oncology, Gynecology, Database study, Claims database

Countries

Japan

Activities

Collapse all

Employment (3)

The University of Tokyo: Tokyo, JP

2023-04-01 to present | Researcher (Graduate school of pharmaceutical sciences)
Employment
Source: Self-asserted source
Yusuke Kajimoto

MSD K.K.: Tokyo, JP

2020-10-01 to present | Senior Scientist (Oncology Science Unit)
Employment
Source: Self-asserted source
Yusuke Kajimoto

Kanagawa Institute of Industrial Science and Technology : Ebina, Kanagawa, JP

2016-04-01 to 2020-06-30 | Researcher (Global Health Research Coordinating Center)
Employment
Source: Self-asserted source
Yusuke Kajimoto

Education and qualifications (2)

The University of Tokyo: Tokyo, JP

2018-04-01 to 2022-03-31 | Ph.D. (Graduate School of Pharmaceutical Sciences)
Education
Source: Self-asserted source
Yusuke Kajimoto

Kyorin University: Tokyo, JP

2015-04-01 to 2017-03-30 | Master of International Medical Cooperation (Graduate school of international cooperation)
Education
Source: Self-asserted source
Yusuke Kajimoto

Professional activities (6)

Japanese Society of Medical Oncology: Tokyo, JP

2021-01-14 to present
Membership
Source: Self-asserted source
Yusuke Kajimoto

QOL/PRO research group: Tokyo, JP

2018-04-01 to present | Member
Membership
Source: Self-asserted source
Yusuke Kajimoto

ISPOR: Blvd South Lawrenceville, NJ, US

2017-04-01 to present | Member
Membership
Source: Self-asserted source
Yusuke Kajimoto

Japan Scoety of Clinical Trials and Research: Tokyo, JP

2019-02-01 to 2022-09-30
Service
Source: Self-asserted source
Yusuke Kajimoto

Gynecologic Cancer InterGroup: Canada, CA

2017-05-30 to 2020-06-30 | Member (Harmonization operation committee)
Membership
Source: Self-asserted source
Yusuke Kajimoto

The Japanese Society for AIDS Research: Tokyo, JP

2017-09-01 to 2019-10-30 | Member
Membership
Source: Self-asserted source
Yusuke Kajimoto

Works (10)

Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer

International Journal of Clinical Oncology
2025-02 | Journal article
DOI: 10.1007/s10147-024-02668-z
Contributors: Kazunori Honda; Yusuke Kajimoto; Shiro Suzuki; Masahiko Mori; Kohshiro Nakao; Anri Azuma; Takashi Shibutani; Shoji Nagao; Takahiro Koyanagi; Izumi Kohara et al.
Source: check_circle
Crossref

Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

Breast Cancer
2023-09 | Journal article
DOI: 10.1007/s12282-023-01479-w
Contributors: Sumito Saeki; Tsuguo Iwatani; Atsuko Kitano; Naomi Sakurai; Yuko Tanabe; Chikako Yamauchi; Ataru Igarashi; Yusuke Kajimoto; Sayaka Kuba; Fumikata Hara et al.
Source: check_circle
Crossref

Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives

Breast Cancer
2023-09 | Journal article
DOI: 10.1007/s12282-023-01476-z
Contributors: Sumito Saeki; Tsuguo Iwatani; Atsuko Kitano; Naomi Sakurai; Yuko Tanabe; Chikako Yamauchi; Ataru Igarashi; Yusuke Kajimoto; Sayaka Kuba; Fumikata Hara et al.
Source: check_circle
Crossref

Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician Perspectives

2023-05-04 | Preprint
DOI: 10.21203/rs.3.rs-2839302/v1
Contributors: Sumito Saeki; Tsuguo Iwatani; Atsuko Kitano; Naomi Sakurai; Yuko Tanabe; Chikako Yamauchi; Ataru Igarashi; Yusuke Kajimoto; Sayaka Kuba; Fumikata Hara et al.
Source: check_circle
Crossref

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

International Journal of Clinical Oncology
2023-03 | Journal article
DOI: 10.1007/s10147-023-02294-1
Contributors: Yusuke Kajimoto; Kazunori Honda; Shiro Suzuki; Masahiko Mori; Hirofumi Tsubouchi; Kohshiro Nakao; Anri Azuma; Takashi Shibutani; Shoji Nagao; Takahiro Koyanagi et al.
Source: check_circle
Crossref

Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database

JCO Global Oncology
2022-11 | Journal article
DOI: 10.1200/GO.22.00227
Contributors: Yusuke Kajimoto; Kazunori Honda; Kazuki Nozawa; Mineko Mukai; Lida Teng; Ataru Igarashi
Source: check_circle
Crossref

Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer

International Journal of Gynecological Cancer
2022-09 | Journal article
DOI: 10.1136/ijgc-2022-003410
Contributors: Yusuke Kajimoto; Takashi Shibutani; Shoji Nagao; Satoshi Yamaguchi; Shiro Suzuki; Masahiko Mori; Hirofumi Tsubouchi; Kohshiro Nakao; Anri Azuma; Takahiro Koyanagi et al.
Source: check_circle
Crossref

GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee

Cancer Treatment Reviews
2022-06 | Journal article | Investigation
DOI: 10.1016/j.ctrv.2022.102396
Part of ISSN: 0305-7372
Contributors: Yusuke Kajimoto
Source: Self-asserted source
Yusuke Kajimoto

Patient and National Economic Burden of Dengue in Japan: Results from Japanese National Claims Database.

The American journal of tropical medicine and hygiene
2020-06-01 | Journal article
DOI: 10.4269/ajtmh.19-0910
PMID: 32314702
PMC: PMC7253128
Source: Self-asserted source
Yusuke Kajimoto

Clinical Management of Patients with Dengue Infection in Japan: Results from National Database of Health Insurance Claims.

The American journal of tropical medicine and hygiene
2020-01-01 | Journal article
DOI: 10.4269/ajtmh.19-0070
PMID: 31701854
PMC: PMC6947782
Source: Self-asserted source
Yusuke Kajimoto
How many people are using ORCID?